| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-adrenergic
stimulation
Department of Physiology, Loyola University Medical Center, Maywood, Illinios 60153
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
METHODS
RESULTS
DISUSSION
REFERENCES
|
|---|
Nitric oxide
(NO) can have a positive or negative effect on cardiac contractility
and the ryanodine receptor (RyR). This dual effect has been explained
as being dependent on the concentration of NO. We find that cellular
RyR response to NO is also dependent on the degree of 
-adrenergic
stimulation, and thus the state of protein kinase A activation.
Ca2+ spark frequency (CaSpF) in rat ventricular myocytes
was used as an index of resting RyR activity. CaSpF response to
-adrenergic stimulation was used as an index of protein kinase A
activation. High concentration of isoproterenol, a
-adrenergic agonist, caused a large increase in CaSpF; addition of
NO (spermine NONOate, 300 µM) then caused a decrease in CaSpF. Low
concentration of isoproterenol produced only a slight increase in
CaSpF, but the same NO concentration now caused a large increase in
CaSpF. A dual effect was also observed in twitch. Thus the net
direction of the effects of NO on RyR activity and Ca2+
transients (directly or by alteration of sarcoplasmic reticulum Ca2+ load) can be reversed, depending on the ambient level
of -adrenergic activation.
protein kinase A; ryanodine receptor; nitrosylation; excitation-contraction coupling
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISUSSION
REFERENCES
|
|---|
CONTRACTION OF CARDIAC MYOCYTES is regulated by a process termed excitation-contraction (EC) coupling (for review, see Ref. 3). Upon depolarization, L-type Ca2+ channels open, which causes an influx of Ca2+ (trigger Ca2+). This trigger Ca2+ then causes the release of Ca2+ from the sarcoplasmic reticulum (SR) in a process termed Ca2+-induced-Ca2+-release (CICR). Release of Ca2+ from the SR occurs through the SR Ca2+ release channel (ryanodine receptor, RyR). Ca2+ sparks are the fundamental unit of SR Ca2+ release (6). Ca2+ sparks can occur stochastically during diastole (independent of Ca2+ influx) (25), but the cellular Ca2+ transient is due to temporal and spatial summation of Ca2+ sparks synchronized by the trigger Ca2+.
An important physiological inotropic pathway is -adrenergic
stimulation. This pathway has been well-characterized in cardiac myocytes. Binding to the -adrenergic receptor leads to activation of
adenylate cyclase, increased cAMP levels, and activation of the
cAMP-dependent protein kinase (PKA). PKA can phosphorylate various
proteins involved in EC coupling, which results in a large increase in
the Ca2+ transient and consequently contractility (e.g.,
13). Phospholamban (PLB) phosphorylation by PKA stimulates SR
Ca2+ uptake and increases the SR Ca2+ load
(e.g., 3). This increase in SR Ca2+ load increases both the
Ca2+ available for release as well as the fractional SR
Ca2+ release during CICR (1). Another protein,
which could be involved in the positive inotropic effect of
-adrenergic stimulation, is the RyR. PKA activation leads to
phosphorylation of RyR (11, 29) and does occur
physiologically in intact rat ventricular myocytes (34).
PKA phosphorylation of RyR can lead to an increase in the channel open
probability (Po) (9), and this may
be due to dissociation of FK-506 binding protein 12.6 from RyR
(19). Thus, resting Ca2+ spark
frequency (CaSpF) increases during -adrenergic stimulation due to
PKA phosphorylation of RyR (to increase Po)
and/or PLB (to increase SR Ca2+ load) (8, 36).
Nitric oxide (NO) is an important modulator of cardiac myocyte contractility (for review see, Ref. 15). NO can interact with proteins involved in EC coupling through two general signaling pathways: cGMP independent and cGMP dependent. NO is known to regulate the L-type Ca2+ channel (e.g., 5, 31) and the RyR (e.g., 35). Interestingly, NO can be a positive or negative inotropic agent. For example, it has been shown that NO can inhibit or stimulate the mammalian L-type Ca2+ current (ICa) in intact myocytes (5, 31). The negative effect of NO on ICa has been shown to occur through both signaling pathways: cGMP-dependent pathway (5, 31) and cGMP-independent pathway (nitrosylation) (12). The positive effect of NO on ICa has also been shown to occur through both pathways: cGMP-dependent pathway (21) or the cGMP-independent pathway (nitrosylation) (5).
This same dual effect (positive and negative) of NO has been observed on the RyR in lipid bilayer through the cGMP-independent pathway (nitrosylation) (28, 33, 35). No studies have investigated the effects of NO on RyR activity in intact cardiac myocytes yet. These different signaling pathways (cGMP dependent and cGMP independent) and effects on proteins involved in EC coupling (positive or negative inotropy) can also affect myocyte shortening. For example, the negative inotropic effect of NO has been shown to be via the cGMP-dependent pathway (e.g., 14, 37), as well as the cGMP-independent pathway (e.g., 23). Furthermore, the positive inotropic effect of NO on myocyte shortening has also been shown to be both cGMP dependent (e.g., 17, 20) and cGMP independent (e.g., 22, 24). Studies postulated that the dual effects of NO are due to the concentration of NO (e.g., 16, 20, 30). Thus low concentrations of NO (and small increase in cGMP levels) will have a positive inotropic effect via inhibition of cGMP-inhibited phosphodiesterase (16) or direct activation of adenylate cyclase (30). High concentrations of NO (and large increases in cGMP) will have a negative inotropic effect via activation of cGMP-dependent protein kinase (16, 30) and resultant inhibition of ICa and/or myofilament Ca2+ sensitivity (26). These studies did not find negative inotropic effects of NO via the cGMP-independent pathway. The effects of NO on cardiac myocyte function are complex due to the dynamics of its signaling pathways and numerous proteins it affects.
The purpose of this study was twofold: to examine the effects of NO on
RyR activity in intact cardiac myocytes and to examine whether the
degree of -adrenergic stimulation also determines the myocyte
response to NO (at a constant concentration of NO). The hypothesis is
that NO will effect RyR function in intact myocytes and that the degree
of -adrenergic stimulation (and thus the state of PKA activation)
will also determine the response of the myocyte to NO, either a
positive (low level of PKA activation) or negative (high level of PKA
activation) inotropic effect.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISUSSION
REFERENCES
|
|---|
Rat Cardiac Myocyte Isolation
Ventricular myocytes were isolated from rat hearts as previously described (2). Briefly, rats were anesthetized by intraperitoneal injection of pentobarbital sodium (100 mg/kg), and the heart from each rat was excised. The hearts were cleaned and flushed with nominally Ca2+-free Tyrode solution consisting of (in mM) 140 NaCl, 4 KCl, 1 MgCl2, 10 glucose, and 5 HEPES (pH = 7.4) and perfused using a Langendorff apparatus. Hearts were perfused with nominally Ca2+-free Tyrode solution for 5 min at 37°C. Perfusion was then switched to the same solution with 1 mg/ml collagenase (type I, Sigma; St. Louis, MO) and 0.16 mg/ml protease (Sigma) for 7 min, after which the heart was washed out with 50 ml of nominally Ca2+-free Tyrode. The heart was then taken down and the tissue minced, triturated, and then filtered. The cell suspension was rinsed and then stored in nominally Ca2+-free Tyrode. Cells were used within 4 h after isolation.Dye Loading and Fluorescence Imaging
Myocytes were loaded with fluo-3 acetoxymethyl ester (AM) as previously described (25). Briefly, myocytes were loaded with fluo-3 AM (20 µM, Molecular Probes; Eugene, OR) for 20 min at room temperature. Excess dye was removed by washing out the dye with bath solution three times and allowing 30 min for intracellular deesterification of fluo-3 AM.Fluorescence imaging was performed, as previously described (25), with a laser scanning confocal microscope (LSM 410, Carl Zeiss), coupled to an inverted microscope (Axiovert 100, Carl Zeiss) and equipped with a ×40 oil immersion objective (Plan-Neofluar, numerical aperature = 1.3; Carl Zeiss). Fluo-3 fluorescence was excited with the 488-nm line of an argon ion laser. Emitted fluorescence was measured at wavelengths >515 nm.
Image acquisition for the analysis of Ca2+ sparks and
Ca2+ transients was made in the line-scan mode, with 512 pixels per line (0.25 µm per pixel) scanned at a sampling rate of 250 lines per second. Images were processed using IDL software (Research
System; Boulder, CO) with intraceullar Ca2+ concentration
([Ca]i) calculated according to the formula
[Ca]i = Kd · (F/Fo)/{(Kd/[Ca]i,rest) + 1 
(F/Fo)}, where Kd is
the dissociation constant for fluo-3, F is the fluorescence intensity, Fo is the intensity at rest, and [Ca]i,rest
is [Ca]i at rest (6). Fo
was determined as the mean fluorescence intensity of the lowest 128 pixels along each line (512 pixels).
Ca2+ sparks were located visually. The fluorescence
intensities of five adjacent pixels of an individual scan line,
centered on the highest pixel value, were averaged and transformed to
[Ca]i as described above. A local increase in
fluorescence was counted as a spark when the peak amplitude exceeded 60 nM and the duration of half amplitude was at least 8 ms. The number of
Ca2+ sparks counted per line scan image was normalized
spatially (per µm3) and temporally (per s) as the spark
frequency (CaSpF; sparks × pl
1 × s1) (pl = picoliter). CaSpF was used as an index of
RyR activity, and the CaSpF response to -adrenergic stimulation was
used as an index of PKA activation. The Ca2+ transients
evoked by electrical stimulation and caffeine application were derived
from the changes in averaged fluorescence intensities along the scanned
line and expressed as F/Fo.
Experimental Protocols
Myocytes were field stimulated via platinum electrodes (0.2 Hz). Cells were superfused with normal Tyrode (22-25°C), and when Ca2+ transients reached steady state, stimulation was stopped, and resting Ca2+ sparks were immediately measured. Sparks were continuously measured for 13.4 s in every protocol. Field stimulation was started again, and the solution was switched to normal Tyrode with isoproterenol (Iso), a-adrerengic agonist (0.01, 0.1, or 1 µM). These different concentrations of Iso were used to achieve different states of PKA
activation. When cell response reached steady state (4 min), stimulation was stopped, and resting Ca2+ sparks were
immediately measured (again for 13.4 s). Field stimulation was
started again, and the solution was switched to normal Tyrode with Iso
and spermine NONOate, a nitric oxide donor (300 µM). When cell
response reached steady state (4 min), stimulation was stopped, and
resting Ca2+ sparks were immediately measured for 13.4 s.
To examine the effect of NO on basal CaSpF, we increased extracellular Ca2+ to 2 mM to increase basal CaSpF so the changes in CaSpF with NO, if any, would be more evident. Once steady state was reached, stimulation was stopped, and resting Ca2+ sparks were immediately measured for 13.4 s. Field stimulation was started again, and the solution was switched to spermine NONOate (300 µM) for 4 min, stimulation was stopped, and resting Ca2+ sparks were immediately measured for 13.4 s. It should be noted that all these protocols ensure that SR Ca2+ stores are filled before observing CaSpF. Moreover, in rat ventricular myocytes there is no change in SR Ca2+ load expected during 13.4 s of rest [and only a modest rise in CaSpF (25)]. The SR Ca2+ content was estimated by rapid application of 10 mM caffeine dissolved in normal Tyrode.
Solutions
The Tyrode solution consisted of (in mM) 140 NaCl, 4 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, and 5 HEPES (pH = 7.4). Iso (1 mM stock) and spermine NONOate were prepared fresh each day. Caffeine (10 mM) and spermine NONOate (300 µM) were dissolved directly in Tyrode solution. 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 mM stock) was dissolved in DMSO. Equivalent concentration of DMSO was added to all solutions (<0.1%). All chemicals were purchased from Sigma except ODQ (Alexis; San Diego, CA).Statistical Analysis
Results were expressed as means ± SE. Statistical significance was determined by repeated-measures ANOVA (followed by Newman-Keuls test). P < 0.05 was considered significant.| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISUSSION
REFERENCES
|
|---|
Effect of NO on Ca2+ Spark Frequency
After -Adrenergic Stimulation
-adrenergic
stimulation. Figure 1 shows
representative experiments performed on a single myocyte when NO had a
positive effect on CaSpF. Line scan images obtained during control
superfusion are shown in Fig. 1A, and there were few
Ca2+ sparks. When the cell was superfused with Iso
(0.01 µM), a -adrenergic agonist, there was a slight increase in
the Ca2+ sparks (Fig. 1B). When the cell was
superfused with Iso and spermine NONOate (300 µM), a NO donor
(Iso + NO), there was a further increase in CaSpF (Fig.
1C).
|
Figure 2 shows representative experiments
performed on a single myocyte when NO had a negative effect on CaSpF.
Figure 2 shows line scan images obtained during control superfusion
where there were few Ca2+ sparks (A), with Iso
(1 µM) (B) where CaSpF was greatly increased compared with
Fig. 1B, and with Iso and spermine NONOate (300 µM) where
CaSpF dramatically decreased (C). This is the opposite NO
affect as was seen in Fig. 1C even though NO concentrations were the same.
|
All cells were separated into two groups based on the response to NO
(positive or negative effect on CaSpF). Pooled data (Fig. 3) show that there was no statistical
difference between the two groups with respect to basal CaSpF (13 ± 6 vs. 17 ± 11 sparks · pl1 · s1,
P = not significant). The cells that exhibited a
positive NO effect were also the cells in which Iso had a small
positive effect (CaSpF only increased to 22 ± 12 sparks · pl1 · s1 and Iso
concentration was typically 0.01 µM). In contrast, when NO had a
negative inotropic effect, the cell had already shown a large response
to Iso to (194 ± 55 sparks · pl1 · s1,
P < 0.05, and in this case Iso concentration was
typically 1 µM).
|
With the small response to Iso, superfusion with spermine NONOate
produced a further fourfold increase of the Iso-stimulated CaSpF (from
22 to 87 ± 21 sparks · pl1 · s1,
P < 0.05 compared with Iso alone). When there was a
large response to Iso, superfusion with spermine NONOate (same
concentration) decreased the Iso-stimulated CaSpF by 53% (from 194 to 91 ± 20 sparks · pl1 · s1,
P < 0.05, compared with Iso alone). Thus, when there
was a large response to Iso (i.e., a higher state of PKA activation),
NO had a negative inotropic effect on CaSpF. When there was a small
response to Iso (i.e., a low state of PKA activation), the same NO
concentration had a positive inotropic effect on CaSpF (see Fig.
3C).
We also examined the effects of NO on basal CaSpF. As Fig.
4A shows, there was no effect
of NO on basal CaSpF (41 ± 21 vs. 36 ± 23 sparks · pl1 · s1,
P = not significant). In these experiments, we raised
extracellular Ca2+ concentration from 1 to 2 mM to raise
CaSpF and enhance our ability to detect NO-dependent changes in
CaSpF. This accounts for the higher basal CaSpF (versus the
Iso experiments). These results indicate that the effect of NO on CaSpF
is dependent on the degree of -adrenergic stimulation and thus the
state of PKA activation.
|
Guanylate Cyclase Involvement in NO-Induced Increase in
-Adrenergic-Stimulated Ca2+ Sparks
-adrenergic stimulation).
These data suggest that the stimulatory effect of NO on CaSpF is
independent of guanylate cyclase activation and cGMP but could be
mediated by other actions (e.g., direct nitrosylation).
Effects of NO on Twitch Ca2+
Transients and SR Ca2+ Load After
-Adrenergic Stimulation
[Ca]i) and SR Ca2+
load. Myocytes were field stimulated at 0.2 Hz, and twitch
[Ca]i was measured under various conditions. SR
Ca2+ load was also measured by rapid caffeine (10 mM)
application. Figure 5 shows the pooled
data for the effects of NO on Ca2+ transients after
-adrenergic stimulation in cardiac myocytes. Figure
5A shows cells that exhibit a positive inotropic effect of
NO. Iso caused an increase in the twitch Ca2+ transient
compared with control (2.5 ± 0.4 vs. 1.7 ± 0.3 F/Fo, P < 0.05). When the cell was
superfused with spermine NONOate (Iso + NO), there was a further
increase in the twitch Ca2+ transient (4.0 ± 0.5 F/Fo, P < 0.05 compared with Iso alone).
|
Figure 5B shows the pooled data for cells where NO had a
negative inotropic effect. Iso caused an increase in the twitch
Ca2+ transient compared with control (2.6 ± 0.5 vs.
2.1 ± 0.5 F/F0, P < 0.05). When the
cell was superfused with spermine NONOate (Iso + NO), there was a
decrease in the twitch Ca2+ transient (2.0 ± 0.4 F/F0, P < 0.05 compared with Iso alone). There was no effect of NO on basal twitch [Ca]i (data
not shown).
One of the main determinants of SR Ca2+ release is the
Ca2+ load of the SR. We examined this by measuring
caffeine-induced Ca2+ transients. Figure
6A shows the overall data of
SR Ca2+ load when NO has a positive inotropic effect. As
expected, Iso caused an increase in SR Ca2+ load compared
with control (4.0 ± 0.4 vs. 3.4 ± 0.4 F/F0,
P < 0.05). When the cell was superfused with spermine
NONOate (Iso + NO), there was a further increase in SR
Ca2+ load (4.6 ± 0.5 F/F0,
P < 0.05 compared with Iso alone). Figure 6B shows the overall data of SR Ca2+ load when
NO has a negative inotropic effect. As expected, Iso caused an increase
in SR Ca2+ load compared with control (5.6 ± 0.8 vs.
5.0 ± 0.8 F/F0, P < 0.05). When the
cell was superfused with spermine NONOate (Iso + NO), there was a
decrease in SR Ca2+ load (4.7 ± 0.7 F/F0,
P < 0.05 compared with Iso alone). There was no effect
of NO on basal SR Ca2+ load (data not shown). These data
suggest that a dual effect of NO on the whole cell Ca2+
transients in intact cardiac myocytes also occurs, and this effect may
be due to the state of PKA activation because the same concentration of
NO was used for the positive and negative effect.
|
| |
DISUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISUSSION
REFERENCES
|
|---|
-Adrenergic stimulation leads to a positive inotropic effect
through activation of PKA and phosphorylation of several proteins involved in EC coupling. One important protein in this pathway is the
SR Ca2+ release channel RyR. Events mediated by RyR have
been identified as Ca2+ sparks. Ca2+ sparks
were used as an index of RyR activity. PKA activation leads to
phosphorylation of RyR (11, 29), which can increase Po (9). PKA also phosphorylates
PLB, which will lead to an increase in SR Ca2+ load (due to
greater SR Ca2+-ATPase activity), and this can also
increase RyR Po (18). This increased Po is seen as an increase in resting
CaSpF (8, 36). Thus the frequency of Ca2+
sparks during -adrenergic stimulation was used as an index of PKA
activation. That is, when there was a small increase in CaSpF, the
functional state of PKA activation was considered to be low. When there
was a large increase in CaSpF, the functional state of PKA activation
was considered to be high. Different concentrations of Iso, a
-adrenergic agonist, were used to generate different states of PKA
activation. In most instances, the high Iso concentration caused a
large increase in CaSpF, and the low Iso concentration caused a small
increase in CaSpF. This is consistent with the higher Iso concentration
activating more PKA and causing a greater -adrenergic response. Thus
we believe CaSpF is a reliable, indirect measure of the functional
state of PKA activation of the entire cell, not just localized to RyR.
NO is also a regulator of cardiac contractility (for review, see Ref. 15). Interestingly, it has been found that NO can have a positive inotropic effect, as well as a negative inotropic effect, on cardiac myocyte function (i.e., myocyte shortening, L-type Ca2+ current, and RyR). Studies have concluded that this dual effect of NO was due to the concentration of NO. That is, high concentrations of NO lead to a negative inotropic effect, whereas low concentrations lead to a positive inotropic effect (10, 16, 20, 30). These differing effects of NO are due to its signaling pathway. NO has two general pathways: cGMP dependent and cGMP independent. Studies have shown that both signaling pathways of NO can produce the positive and negative inotropic effects (see INTRODUCTION). Hence, the effect of NO on myocyte contractility is multifaceted and probably dependent on other factors, not just NO concentration. The object of this study was twofold: to determine whether NO regulation of RyR activity occurs in intact cardiac myocytes and to examine whether the state of PKA activation alters the myocyte response to NO. The RyR activity was selected to examine the effect of PKA activation on NO effects for two reasons: 1) RyR gating can be both stimulated or inhibited by NO in lipid bilayer studies (28, 33, 35), and 2) PKA activation state can be inferred from CaSpF.
PKA Activation and Response to NO
When there was a large increase in CaSpF in response to-adrenergic stimulation (1,392% increase from control), we infer that there was a high state of PKA activation. Perfusion with NO in
this case attenuated the -adrenergic-stimulated CaSpF (53% decrease
of Iso response) and had a negative inotropic effect (Figs. 2 and 3).
When there was a small increase in CaSpF in response to -adrenergic
stimulation (29% increase from control, i.e., a low state of PKA
activation), NO caused a further increase in CaSpF (295% increase of
Iso response) and a positive inotropic effect (Figs. 1 and 3). These
data indicate that the state of PKA activation (1,392% vs. 29%) can
be a crucial predisposing factor that can determine whether NO will be
a negative or positive inotropic agent (53% vs. +295%). There was
no effect of NO on basal CaSpF (Fig. 4A). These data are in
agreement with the majority of literature that shows NO does not effect
basal cardiac function (e.g., 31). Thus the purpose of NO may be to
regulate (or fine tune) the myocyte's response to -adrenergic
stimulation (further enhance or attenuate). That is, when there is a
high state of -adrenergic stimulation, NO will have a negative
inotropic effect to prevent Ca2+ overload. When there is a
low state of -adrenergic stimulation, NO will have a positive
inotropic effect to enhance the -adrenergic response.
NO Effect on CaSpF: cGMP Independent or Dependent?
The effect of NO on RyR activity is thought to be mediated mainly by nitrosylation (cGMP independent). Preliminary results from our lab have shown that the negative inotropic effect of NO (produced via inducible NOS) on RyR activity was through the cGMP-independent pathway (38). Our results here with ODQ, a specific inhibitor of NO stimulation of guanylate cyclase (7), imply that the positive effect of NO on CaSpF is independent of guanylate cyclase and cGMP (Fig. 4B). Previous work has shown that ODQ is a specific inhibitor of guanylate cyclase in cardiac myocytes (ODQ selectively decreased cGMP levels in response to NO donors) (27). Because ODQ did not alter the effects of NO on-adrenergic-stimulated CaSpF, we conclude that the effect of NO to
increase RyR activity is likely to be a direct effect via nitrosylation
of a target protein. These data also agree with other studies that have
shown NO can alter the gating activity of RyR incorporated into lipid
bilayers via nitrosylation (28, 33, 35). Interestingly,
two of these three studies found that nitrosylation of cardiac RyR led
to increased probability of channel opening (28,
33), whereas the other found decreased probability (35). This may be due to different conditions in the
bilayer, different redox states of RyR, different types of NO donors,
different levels of NO produced, etc. In fact, Hart and Dulhunty
(10) found a dual effect of NO (positive and negative),
which was dependent on NO concentration (high vs. low), using RyR from
skeletal muscle in lipid bilayers. Our data are consistent with the
effect of NO on RyR activity being via the cGMP-independent pathway.
Our data here suggest that there may also be different PKA
phosphorylation states of RyR, which will respond differently to NO.
What is Cellular Target of NO to Alter Twitch Ca2+ Transients?
To understand mechanistically how NO alters twitch Ca2+ transients, one must consider the molecular targets of NO. A NO-induced change in-adrenergic-stimulated CaSpF (Fig. 3) and
twitch Ca2+ transients (Fig. 5) could be due to changes in
RyR, PLB, and/or L-type Ca2+ channel.
RyR. If the dominant effect of NO to increase twitch Ca2+ transients (Fig. 5A) were via a direct nitrosylation of RyR to increase Po, then the SR Ca2+ load would decrease. However, the NO-induced increase in twitch Ca2+ transients is associated with an increase in SR Ca2+ load (Fig. 6A). Additionally, if the effect of NO to decrease twitch Ca2+ transients (Fig. 5B) were via a direct nitrosylation of RyR to decrease Po, then the SR Ca2+ load would increase. However, the opposite effect occurred (Fig. 6B). Thus the primary effect of NO to alter twitch Ca2+ transients must be due to changes in SR Ca2+ uptake (seen as changes in SR Ca2+ load). This does not preclude direct alterations of RyR function by NO, but this may not be the primary pathway. When NO decreased CaSpF (Figs. 2 and 3B) and twitch Ca2+ transients (Fig. 5B), there was a high CaSpF and SR Ca2+ load (Fig. 6B) with Iso (indication of greater SR Ca2+ uptake via higher PKA activity). When NO increased CaSpF (Figs. 1 and 3A) and twitch Ca2+ transients (Fig. 5A), there was a low CaSpF and SR Ca2+ load with Iso (indicative of lower SR Ca2+ uptake via lower PKA activity). Therefore, it may be the PKA-regulated change in SR Ca2+ load (or phosphorylation of a PKA target) that dictates whether NO is inhibitory or stimulatory.
Although the mechanism of how NO altered SR Ca2+ load was not examined in this study, it could be speculated that NO-induced changes in phosphorylation levels of PLB and/or the L-type Ca2+ channel would lead to a change in SR Ca2+ load. We cannot distinguish whether this positive or negative effect of NO are via the same molecular target.PLB and negative effect of NO?
For example, we recently found that NO can decrease phosphorylation
levels of PLB, in a cGMP-independent pathway, after a high degree of
-adrenergic stimulation (27). Thus the negative effect
of NO on CaSpF (Fig. 3B), twitch Ca2+ transients
(Fig. 5B), and SR Ca2+ load (Fig. 6B)
could simply be explained by NO-induced changes in SR Ca2+
load via modifications in PLB phosphorylation, as our previous study demonstrated.
L-type Ca2+ Channel and positive effect of NO? The positive effect of NO could be via stimulation of SR Ca2+ uptake by increasing ICa. We have shown here that the positive effect of NO on CaSpF is cGMP independent (Fig. 4B). Data in the literature suggest that the positive effect of NO on ICa is also cGMP independent (5), which is consistent with our data presented here. However, the negative effect of NO on ICa is cGMP dependent (5, 31), which does not match our data. Thus the positive effect of NO on CaSpF (Fig. 3A), twitch Ca2+ transients (Fig. 5A), and SR Ca2+ load (Fig. 6A) could be explained by NO-induced changes in SR Ca2+ load via modification of ICa. But these speculations will require further experimental tests.
In conclusion, we have shown that NO can alter (either as a positive or negative inotropic agent)-adrenergic-stimulated Ca2+
spark frequency, an index of RyR activity. This response may be a
direct effect of NO on RyR or may also be dependent on the state of
PKA-regulated change in SR Ca2+ load. Thus, not only the
concentration of NO, but also the degree of -adrenergic stimulation
is a determinant of the effect, positive or negative, of NO. This
effect of NO on Ca2+ handling may also have clinical
implications, because in human heart failure where -adrenergic
signaling is altered (4), RyR is hyperphosphorylated
(19) and NO production is increased (32).
Thus NO effects may contribute to altered Ca2+ uptake and
release events in heart failure.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. Lars S. Maier and Dr. Thomas Shannon for helpful discussions and comments on the manuscript.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-10122 (to M. T. Ziolo) HL-64098, and HL-64724 (to D. M. Bers).
Address for reprint requests and other correspondence: D. M. Bers, Dept. of Physiology, Loyola Univ. Medical Center, 2160 South First Ave., Maywood, IL 60153 (E-mail: dbers{at}lumc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1 June 2001; accepted in final form 23 August 2001.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISUSSION
REFERENCES
|
|---|
1.
Bassani, JWM,
Yuan W,
and
Bers DM.
Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes.
Am J Physiol Cell Physiol
268:
C1313-C1329,
1995
2.
Bers, DM,
Lederer WJ,
and
Berlin JR.
Intracellular Ca transients in rat cardiac myocytes: role of Na-Ca exchange in excitation contraction coupling.
Am J Physiol Cell Physiol
258:
C944-C954,
1990
3.
Bers, DM.
Excitation-Contraction Coupling and Cardiac Contractile Force (2nd ed.). Dordrecht, The Netherlands: Kluwer Academic, 2001.
4.
Bristow, MR,
Ginsburg R,
Minobe W,
Cubicciotti RS,
Sageman WS,
Lurie K,
Billingham ME,
Harrison DC,
and
Stinson EB.
Decreased catecholamine sensitivity and -adrenergic-receptor density in failing human hearts.
N Engl J Med
307:
205-211,
1982[Abstract].
5.
Campbell, DL,
Stamler JS,
and
Strauss HC.
Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual mechanism regulation by nitric oxide and S-nitrosothiols.
J Gen Physiol
108:
277-293,
1996
6.
Cheng, H,
Lederer WJ,
and
Cannel MB.
Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle.
Science
262:
740-744,
1993
7.
Garthwaite, J,
Southam E,
Boulton CL,
Nielsen EB,
Schmidt K,
and
Mayer B.
Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Mol Pharmacol
48:
184-188,
1995[Abstract].
8.
Gomez, AM,
Cheng H,
Lederer WJ,
and
Bers DM.
Ca2+ diffusion and sarcoplasmic reticulum transport both contribute to [Ca2+]i decline during Ca2+ sparks in rat ventricular myocytes.
J Physiol (Lond)
496:
575-581,
1996[ISI][Medline].
9.
Hain, J,
Onoue H,
Mayrleitner M,
Fleisher S,
and
Schindler H.
Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle.
J Biol Chem
270:
2074-2081,
1995
10.
Hart, JDE,
and
Dulhunty AF.
Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding.
J Membr Biol
173:
227-236,
2000[ISI][Medline].
11.
Hohenegger, M,
and
Suko J.
Phosphorylation of the purified cardiac ryanodine receptor by exogenous and endogenous protein kinases.
Biochem J
296:
303-308,
1993.
12.
Hu, H,
Chiamvimonvat N,
Yamagishi T,
and
Marban E.
Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors.
Circ Res
81:
742-752,
1997
13.
Hussain, M,
and
Orchard CH.
Sarcoplasmic reticulum Ca2+ content, L-type Ca2+ current and the Ca2+ transient in rat myocytes during -adrenergic stimulation.
J Physiol (Lond)
505:
385-402,
1997[ISI][Medline].
14.
Joe, EK,
Schussheim AE,
Longrois D,
Maki T,
Kelly RA,
Smith TW,
and
Balligand JL.
Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide.
J Mol Cell Cardiol
30:
303-315,
1998[ISI][Medline].
15.
Kelly, RA,
Balligand JL,
and
Smith TW.
Nitric oxide and cardiac function.
Circ Res
79:
363-380,
1996
16.
Kojda, G,
Kottenberg K,
Nix P,
Schluter KD,
Piper HM,
and
Noack E.
Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes.
Circ Res
78:
91-101,
1996
17.
Kojda, G,
Kottenberg K,
and
Noack E.
Inhibition of nitric oxide and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts.
Eur J Pharmacol
334:
181-190,
1997[ISI][Medline].
18.
Lukyanenko, V,
Viatchenko-Karpinski S,
Smirnov A,
Wiesner TF,
and
Gyorke S.
Dynamic regulation of sarcoplasmic reticulum Ca2+ content and release by luminal Ca2+-sensitive leak in rat ventricular myocytes.
Biophys J
81:
785-798,
2001
19.
Marx, SO,
Reiken S,
Hisamatsu Y,
Jayaraman T,
Burkhoff D,
Rosemblit N,
and
Marks AR.
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.
Cell
101:
365-367,
2000[ISI][Medline].
20.
Mohan, P,
Brutsaert DL,
Paulus WJ,
and
Sys SU.
Myocardial contractile response to nitric oxide and cGMP.
Circ Res
93:
1223-1229,
1996.
21.
Ono, K,
and
Trautwein W.
Potentiation by cyclic GMP of -adrenergic effect on Ca2+ current in guinea-pig ventricular cells.
J Physiol (Lond)
443:
387-404,
1991
22.
Paolocci, N,
Ekelund UEG,
Isoda Y,
Ozaki M,
Vandegaer K,
Georgakopoulos D,
Harrison RW,
Kass DA,
and
Hare JM.
cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation.
Am J Physiol Heart Circ Physiol
279:
H1982-H1988,
2000
23.
Sandirasegarane, L,
and
Diamond J.
The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
J Mol Cell Cardiol
31:
799-808,
1999[ISI][Medline].
24.
Sarkar, D,
Vallance P,
Amirmansour C,
and
Harding SE.
Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides.
Cardiovasc Res
48:
430-439,
2000
25.
Satoh, H,
Blatter LA,
and
Bers DM.
Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes.
Am J Physiol Heart Circ Physiol
272:
H657-H668,
1997
26.
Shah, AM,
Spurgeon HA,
Sollott SJ,
Talo A,
and
Lakatta EG.
8-Br-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes.
Circ Res
74:
970-978,
1994
27.
Stojanovic, MO,
Ziolo MT,
Wahler GM,
and
Wolska BM.
Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes.
Am J Physiol Cell Physiol
281:
C342-C349,
2001
28.
Stoyanovsky, D,
Murphy T,
Anno PR,
Kim YM,
and
Salama G.
Nitric oxide activates skeletal and cardiac ryanodine receptors.
Cell Calcium
21:
19-29,
1997[ISI][Medline].
29.
Takasago, T,
Imagawa T,
and
Shigekawa M.
Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase.
J Biochem (Tokyo)
106:
872-877,
1989
30.
Vila-Petroff, MG,
Younes A,
Egan J,
Lakatta EG,
and
Sollott SJ.
Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.
Circ Res
84:
1020-1031,
1999
31.
Wahler, GM,
and
Dollinger SJ.
Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase.
Am J Physiol Cell Physiol
268:
C45-C54,
1995
32.
Winlaw, DS,
Smythe GA,
Keogh AM,
Schyvnes CG,
Spratt PM,
and
Macdonald PS.
Nitric oxide production and heart failure.
Lancet
345:
390-391,
1995[ISI][Medline].
33.
Xu, L,
Eu JP,
Meissner G,
and
Stamler JS.
Activation of cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.
Science
279:
234-237,
1998
34.
Yoshida, A,
Takahashi M,
Imagawa T,
Shigekawa Takishawa H M,
and
Nakamura T.
Phosphorylation of ryanodine receptors in rat myocytes during -adrenergic stimulation.
J Biochem
111:
186-190,
1992
35.
Zahradnikova, A,
Minarovic I,
Venema RC,
and
Meszaros LG.
Inactivation of the cardiac calcium release channel by nitric oxide.
Cell Calcium
22:
447-453,
1997[ISI][Medline].
36.
Zhou, YY,
Song LS,
Lakatta EG,
Xiao RP,
and
Cheng H.
Constitutive 2-adrenergic signaling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart.
J Physiol (Lond)
521:
351-361,
1999
37.
Ziolo, MT,
Dollinger SJ,
and
Wahler GM.
Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguandine.
J Mol Cell Cardiol
30:
1009-1017,
1998[ISI][Medline].
38.
Ziolo, MT,
Katoh H,
and
Bers DM.
Nitric oxide (NO) produced by iNOS attenuates the cAMP/PKA response in intact rat ventricular myocytes by depressing ryanodine receptors (RyR) activity (Abstract).
Circulation
100:
573,
1999.
This article has been cited by other articles:
|
|
 |
|
  G. Lim, L. Venetucci, D. A. Eisner, and B. Casadei Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling Cardiovasc Res, January 15, 2008; 77(2): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kawai, T. Kawai, J. T. Sambol, D.-Z. Xu, Z. Yuan, F. J. Caputo, C. D. Badami, E. A. Deitch, and A. Yatani Cellular mechanisms of burn-related changes in contractility and its prevention by mesenteric lymph ligation Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2475 - H2484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Tocchetti, W. Wang, J. P. Froehlich, S. Huke, M. A. Aon, G. M. Wilson, G. Di Benedetto, B. O'Rourke, W. D. Gao, D. A. Wink, et al. Nitroxyl Improves Cellular Heart Function by Directly Enhancing Cardiac Sarcoplasmic Reticulum Ca2+ Cycling Circ. Res., January 5, 2007; 100(1): 96 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Secondo, A. Pannaccione, M. Cataldi, R. Sirabella, L. Formisano, G. Di Renzo, and L. Annunziato Nitric oxide induces [Ca2+]i oscillations in pituitary GH3 cells: involvement of IDR and ERG K+ currents Am J Physiol Cell Physiol, January 1, 2006; 290(1): C233 - C243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.J.F. Danson, Y.H. Zhang, C.E. Sears, A.R. Edwards, B. Casadei, and D.J. Paterson Disruption of inhibitory G-proteins mediates a reduction in atrial {beta}-adrenergic signaling by enhancing eNOS expression Cardiovasc Res, September 1, 2005; 67(4): 613 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Llach, J. Huang, F. Sederat, L. Tort, G. Tibbits, and L. Hove-Madsen Effect of {beta}-adrenergic stimulation on the relationship between membrane potential, intracellular [Ca2+] and sarcoplasmic reticulum Ca2+ uptake in rainbow trout atrial myocytes J. Exp. Biol., March 15, 2004; 207(8): 1369 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, J. Petranka, K. Yamamura, R. E. London, C. Steenbergen, and E. Murphy Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2657 - H2662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.B. Massion, O. Feron, C. Dessy, and J.-L. Balligand Nitric Oxide and Cardiac Function: Ten Years After, and Continuing Circ. Res., September 5, 2003; 93(5): 388 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Ziolo and D. M. Bers The Real Estate of NOS Signaling: Location, Location, Location Circ. Res., June 27, 2003; 92(12): 1279 - 1281. [Full Text] [PDF]
|
|
|
|
|
|
Z. Z. Kojic, U. Flogel, J. Schrader, and U. K. M. Decking Endothelial NO formation does not control myocardial O2 consumption in mouse heart Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H392 - H397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Ziolo, H. Katoh, and D. M. Bers Expression of Inducible Nitric Oxide Synthase Depresses {beta}-Adrenergic-Stimulated Calcium Release From the Sarcoplasmic Reticulum in Intact Ventricular Myocytes Circulation, December 11, 2001; 104(24): 2961 - 2966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Hintze Prologue: Nitric oxide-hormones, metabolism, and function Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2253 - H2255. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||
